The obesity societies advise: If you cannot find or get access to a GLP-1-based treatment now, there are other treatments available, echoing experts
Or you may need to change the times you take the supplements until your treatment is complete
Cash-pay telehealth weight loss was the early model (companies like Ro, Hims, Calibrate): Monthly membership fee ($50-200) Plus cost of medication (either marked up through compounding pharmacies or retail GLP-1s) Patients pay out of pocket entirely Pros: No insurance billing hassle Higher margins per patient if you mark up medications Cons: Limited to affluent patients High churn when patients cant afford $300-500/month ongoing Regulatory scrutiny (many compounded semaglutide products were investigated for safety) Insurance-based model is becoming more viable: Bill insurance for visits (E/M codes) Send GLP-1 prescription to patients pharmacy (they use insurance for medication) You get paid per visit (~$100-150), patient pays copay Pros: Larger addressable market (anyone with obesity diagnosis and insurance) More sustainable (patients can afford to stay on therapy long-term) Less regulatory risk (using FDA-approved products through licensed pharmacies) Cons: Prior authorization burden Payment delays from insurers Need credentialing with multiple payers Hybrid approach: Some practices bill insurance when possible, offer cash-pay as backup for patients with exclusions
Terms of Sale: By purchasing from Midwest Peptide, the buyer confirms they are a qualified researcher or institution
You can then select the same mental health program to pick up where you left off
He frames it as triggering collagen production, repairing tissue, and helping regrow thinning hair (source)
